KOSDAQRetail & Consumer018700

Jolse

₩1,140▲ 0.62%2026-11-18 close
Market Cap
₩19.1B
Turnover
₩5,636,937
Volume
5K
Shares out.
16.7M
PER
—
PBR
0.4×
EPS
-₩278
Dividend Yield
0.00%

PER, EPS, PBR and BPS are calculated in-house from the last 4 quarters (2025Q4–2026Q3) · Dividend yield is based on ₩0 per share · Prices as of the 2026-11-18 close

01

Report overview

Narrowing losses and restructuring; recovery remains the test

Jolse recorded operating losses in each year from 2022 through 2025, returned to operating profit in the second quarter of 2026, and slipped back into an operating loss in the third quarter, so the durability of profits is the next thing to watch.

  1. 1

    Annual revenue peaked at KRW 67.9 billion in 2024 and fell 5.4% to KRW 64.2 billion in 2025.

  2. 2

    The operating loss narrowed from KRW 5.73 billion in 2024 to KRW 3 billion in 2025, and the operating margin improved to -4.7%.

  3. 3

    Third-quarter 2026 revenue was KRW 12.1 billion, down 32.0% year on year, and the company swung to an operating loss of KRW 600 million.

  4. 4

    A KRW 10 billion third-party share placement announced in May 2026 aims to strengthen the balance sheet, and the company said a private beauty distributor would become the new largest shareholder upon payment.

  5. 5

    Restructuring and wider North American distribution are the bullish factors, while accumulated deficits, reported as five consecutive fiscal years of operating losses, and the KOSDAQ market-cap rule remain the bearish ones.

02

Business structure

Jolse (018700) changed its name from Barunson in March 2026 and is centered on K-beauty cosmetics distribution. The company said its own online platform, Jolse.com, sells products from more than 250 K-beauty brands in about 180 countries.

According to FnGuide, the December 2025 revenue mix was Beauty 80.29%, VFX (visual effects) 9.52%, Others 8.26%, and Film 1.93%. The beauty share rose from 65.11% in December 2024, while the VFX share fell from 18.34% over the same period.

The company has said it is gradually scaling back lower-margin businesses to focus resources on global cosmetics distribution. Its channel expansion has centered on North America, with listings at Ulta Beauty, iHerb and TJX, while supply talks with Costco are ongoing.

Exports accounted for 54.5% of 2025 revenue on a December 2025 basis, larger than the 45.5% domestic share. Product sourcing is driven by country-specific consumer data gathered from its overseas self-operated mall.

Competition centers on securing K-beauty platforms and overseas distribution channels, and a listed peer in the same sector is iMarketKorea.

03

Earnings trend

Quarterly revenue · Operating profit
RevenueOperating profit
Annual revenue · Operating profit
RevenueOperating profit
Quarterly results · Last 5 quarters
QuarterRevenueOperating profitOp. margin
2025Q3₩17.8B₩200M1.0%
2025Q4₩12.9B-₩3.7B−28.5%
2026Q1₩11.2B-₩1.4B−12.1%
2026Q2₩12.3B₩2.7B22.2%
2026Q3₩12.1B-₩600M−5.0%
Annual results
YearRevenueOperating profitNet income (parent)Op. marginROEDebt-to-equity
2022₩58.7B-₩5.2B-₩24.9B−8.8%−42.4%51.0%
2023₩61.5B-₩5.7B-₩15.7B−9.3%−36.8%60.8%
2024₩67.9B-₩5.7B-₩13.4B−8.4%−45.8%60.2%
2025₩64.2B-₩3B-₩2.6B−4.7%−9.8%48.1%

Consolidated basis (financial statements including subsidiaries) · Final figures from DART filings · Net income attributable to owners of the parent · Data as of 2026-11-18

04

Earnings analysis

Annual revenue rose from KRW 58.7 billion in 2022 to KRW 61.5 billion in 2023 (up 4.8% year on year) and KRW 67.9 billion in 2024 (up 10.4%), then fell to KRW 64.2 billion in 2025 (down 5.4%). Among 2022 to 2025, 2024 was the largest year for revenue and 2022 the smallest.

The operating loss was KRW 5.16 billion in 2022, KRW 5.69 billion in 2023 and KRW 5.73 billion in 2024, a continued loss that widened, before narrowing to KRW 3 billion in 2025, also a continued loss. The operating margin moved from -8.8% to -9.3%, then -8.4%, and -4.7% in 2025, the largest improvement in the period.

Loss attributable to controlling shareholders shrank each year, from KRW 24.9 billion in 2022 to KRW 15.7 billion, KRW 13.4 billion and KRW 2.61 billion in 2025.

Net loss including non-controlling interests was KRW 25.3 billion, KRW 16 billion, KRW 13.5 billion and KRW 3.15 billion, a different measure from the controlling-shareholder figure.

The gap between the 2022 operating loss of KRW 5.16 billion and the controlling-shareholder net loss of KRW 24.9 billion is large, suggesting non-operating items weighed heavily that year.

Operating cash flow went from a KRW 4.64 billion inflow in 2022 to outflows of KRW 5.08 billion in 2023, KRW 5.93 billion in 2024 and KRW 3.66 billion in 2025, with the outflow narrowing in 2025.

The debt-to-equity ratio was 51.0% in 2022, 60.8% in 2023, 60.2% in 2024 and 48.1% in 2025, when total liabilities stood at KRW 12.8 billion.

Quarterly, an operating profit of KRW 178 million in the third quarter of 2025 turned into an operating loss of KRW 3.68 billion in the fourth quarter, and the first quarter of 2026 showed a narrower loss of KRW 1.36 billion.

The second quarter of 2026 swung to an operating profit of KRW 2.72 billion on revenue of KRW 12.3 billion (up 9.5% quarter on quarter), which the company attributed to its business restructuring.

The third quarter of 2026 returned to an operating loss of KRW 600 million on revenue of KRW 12.1 billion (down 32.0% year on year). Controlling-shareholder net losses over the last four quarters total KRW 3.51 billion.

05

Industry analysis

Jolse runs two businesses: K-beauty cosmetics distribution aimed at overseas consumers, and content businesses such as VFX and film. With cosmetics distribution above 80% of revenue as of December 2025, results depend mainly on performance in overseas K-beauty distribution channels.

Expansion of North American distribution is the central variable. Listings at Ulta Beauty, iHerb and TJX are widening its overseas sales base. Even so, revenue can swing with the order size of individual channel partners.

On the content side, the VFX share fell from 18.34% in December 2024 to 9.52% in December 2025, and the film share fell from 10.58% to 1.93% over the same period. That fits the company's stated plan to scale back lower-margin businesses.

On competition, Jolse highlights its brand sourcing and country-specific consumer data as differentiators. It competes for position in K-beauty distribution with listed peers in the same sector, such as iMarketKorea.

Its market capitalization is small and sits near the KRW 20 billion threshold that KOSDAQ uses for administrative-issue designation.

06

Outlook

The KRW 10 billion third-party share placement disclosed in May 2026 was planned to fund product purchases, personnel costs and marketing, with KRW 4 billion scheduled for 2026 and KRW 6 billion for 2027.

A private beauty distributor was to take all the new shares, and the company said that distributor would become the new largest shareholder once payment was completed.

The change in largest shareholder depended on payment being completed by late July 2026, and the new shares were reported as scheduled to list on KOSDAQ on August 25, 2026. The company said it is focused on strengthening its core business, improving results and securing financial stability.

At an extraordinary shareholders meeting on September 10, 2026, experts in beauty, global sales and finance were appointed as new directors.

On the business side, supply talks with Costco are ongoing after listings at Ulta Beauty, iHerb and TJX, and the company plans to expand support for overseas entry by domestic K-beauty brands. How quickly channel growth turns into revenue and profit still has to be checked against reported quarterly results.

Because the second quarter of 2026 swung to profit and the third quarter returned to an operating loss, whether quarterly operating profit can hold is the next checkpoint.

07

Valuation

PER
—
PBR
0.4×
ROE
-10.1%
EPS
-₩278
BPS
₩2,914
Dividend per share
₩0

The PER cannot be calculated because the controlling-shareholder net losses over the last four quarters total KRW 3.51 billion. With earnings negative, valuation leans on net-asset measures rather than earnings multiples.

The price-to-book ratio sits below 1x, which means the share price is well under book value per share. However, accumulated deficits of KRW 119.3 billion as of the end of the first quarter of 2026 mean the net asset base could change with future capital movements. The dividend yield is below the industry average.

Market capitalization is hovering near the KRW 20 billion level used as the KOSDAQ administrative-issue benchmark, so that threshold acts as a constraint in any valuation discussion. Past PER bands are of limited use because long stretches of losses leave no meaningful range.

PER, EPS, PBR and BPS are all calculated in-house (the same method as Naver and Toss) · Dividend yield = cash dividend per share from DART filings (supplemented by KRX) ÷ current price · As of 2026-11-18

08

Bull factors

Restructuring and a return to quarterly profit

Operating profit returned to KRW 2.72 billion in the second quarter of 2026, which the company attributed to shrinking non-core businesses and a profit-focused approach. The beauty share rose to 80.29% as of December 2025, narrowing the business toward cosmetics distribution. The operating margin improved from -8.8% in 2022 to -4.7% in 2025.

Wider North American distribution

Listings at Ulta Beauty, iHerb and TJX broaden the overseas base, and supply talks with Costco are ongoing, which adds room to diversify channels. The export share was 54.5% as of December 2025, so the overseas sales base is larger than domestic sales.

Narrowing losses and lower leverage

The operating loss narrowed from KRW 5.73 billion in 2024 to KRW 3 billion in 2025, and the controlling-shareholder net loss shrank to KRW 2.61 billion. The debt-to-equity ratio fell from 60.2% to 48.1% over the same period. The operating cash outflow also narrowed to KRW 3.66 billion in 2025.

09

Bear factors

Shrinking revenue and a renewed third-quarter loss

In the third quarter, revenue declined and an operating loss reappeared. Annual revenue also fell 5.4% in 2025. Because the second-quarter profit came in a single quarter, the durability of profit is still unproven.

Accumulated deficits and partial capital impairment

Accumulated deficits reached KRW 119.3 billion at the end of the first quarter of 2026, and a news report described partial capital impairment, with equity of KRW 25.6 billion below capital stock of KRW 35.1 billion.

Press reports described five consecutive fiscal years of operating losses and an investment-caution designation. The filed results show four consecutive years of losses from 2022 through 2025.

Reliance on external funding and an ownership change

A KRW 10 billion third-party share placement in May 2026 raised funds, and the company said a private distributor would become the new largest shareholder upon payment. Proceeds are scheduled for use in 2026 and 2027. A change of chief executive and a reshuffled board add questions about strategy continuity.

10

Risk factors

Administrative-issue designation and market-cap rule

Under KOSDAQ listing rule 53, a common-share market cap below KRW 20 billion for 30 consecutive trading days leads to administrative-issue designation. Press reports in July 2026 described 25 consecutive trading days below the threshold.

Market capitalization is currently still under that line, so meeting the requirement is a major risk alongside supply-and-demand volatility.

Channel concentration and earnings volatility

Even as North American listings grow, quarterly revenue can move sharply with the order size of individual channel partners. Quarterly revenue ran at KRW 11.2 billion, KRW 12.3 billion and KRW 12.1 billion across the first three quarters of 2026, showing continued variation. With 54.5% of sales exported as of December 2025, currency and logistics costs could also affect profitability.

Execution risk in the business transition

The company renamed itself in March 2026 and is scaling back non-core businesses, with the VFX and film shares at 9.52% and 1.93% as of December 2025. Because shrinking those businesses also reduces revenue, whether profit-focused operations can coincide with a revenue recovery is the open question.

An ownership change and board reshuffle overlapping with this transition add uncertainty over strategic consistency.

11

What to watch next

  1. Late December 2026

    Whether common-share market capitalization returns above the KRW 20 billion line and whether the 30-trading-day shortfall condition is resolved. An administrative-issue designation would directly affect trading liquidity.

  2. January to February 2027 (expected timing of the fourth-quarter 2026 preliminary results)

    Whether the fourth quarter of 2026 returns to operating profit and how much revenue recovers. Whether the second-quarter profit and third-quarter loss show a clear trend is the key test.

  3. Late March 2027

    The 2026 annual report should show the full-year operating margin, debt-to-equity ratio, total equity and controlling-shareholder equity. It will also show whether the partial capital impairment seen in early 2026 was resolved on an annual basis.

  4. Mid-May 2027 (deadline for the first-quarter 2027 quarterly report)

    The direction of first-quarter 2027 operating profit and controlling-shareholder net income, and how the 2027 use of the share placement proceeds appears in revenue and marketing spending.

12

Overall view

Jolse recorded operating losses from 2022 through 2025, but the size of the loss and the operating margin both improved in 2025. A second-quarter 2026 return to operating profit was followed by a third-quarter loss, so whether quarterly profit holds is the most important checkpoint now.

Bullish factors include restructuring, wider North American distribution and a lower debt-to-equity ratio, while bearish factors include falling revenue, accumulated deficits, the market-cap rule and reliance on external funding.

On valuation, the PER cannot be calculated and the share price sits well below net asset value per share, while the administrative-issue threshold acts as a constraint. The next step is to check full-year operating margin and capital structure in the 2026 annual report. This report is for information only and does not include an investment opinion.

13

Sources

  1. Korea Exchange (KRX) — Prices · Market Cap · Volume
  2. FSS electronic disclosure system (DART) — Financial statements · Dividend filings
Show 18 more articles and sources
  1. marketin.edaily.co.kr
  2. m.finance.daum.net
  3. comp.fnguide.com
  4. newstomato.com
  5. news.nate.com
  6. v.daum.net
  7. newstomato.com
  8. ibtomato.com
  9. news.nate.com
  10. edaily.co.kr
  11. tradingkey.com
  12. zdnet.co.kr
  13. m.news.nate.com
  14. kr.investing.com
  15. tradingkey.com
  16. globenewswire.com
  17. kr.investing.com
  18. uk.investing.com

Report written 2026-11-18 · Data as of 2026-11-17

This content is AI analysis of market data and web search results, provided for information only. It is not a solicitation or recommendation to invest. Investment decisions and their consequences are the investor's own responsibility. Data may be delayed or contain errors.

Other reports in this industry

View industry analysis